Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
sf1126 (4 trials)
Carcinoma (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Squamous Cell (Phase 2)
Neoplasms (Phase 1)
Neuroblastoma (Phase 1)
Trials (4 total)
Trial APIs (1 total)